Call for Papers: Special Issue on GPCRs - ACS Axial | ACS Publications

Call for Papers: Special Issue on GPCRs

ACS Pharmacology & Translational Science is planning to publish a special issue on G protein-coupled receptors (GPCRs) in early 2019, and its editors would like to invite researchers working in this area to submit a paper.

“I am currently promoting awareness of this endeavor in case you may have research that is nearing submission that would be a good fit for the scope of the journal,” says Editor-in-Chief Professor Patrick M. Sexton. “Our laboratory will be contributing original research for review for potential inclusion in this issue.”

Submit your latest research on GPCRs

Priority Review for Papers on GPCRs

The journal’s editorial team will be implementing a priority review process for papers on GPCRs that are submitted for inclusion in this special issue by the end of November, says Professor Sexton. This will include providing initial reviews within two weeks of submission.

ACS Pharmacology & Translational Science can also provide rapid processing from formal acceptance of a paper to fully-formatted online publication. Where authors are responsive to the production team, this is normally achievable within one week of acceptance.

What to Submit

“GPCRs are premier pharmaceutical drug targets, and we are looking forward to publishing the latest advances in GPCR research that are providing translational understanding in GPCR function, and how this may be applied to disease treatment,” says Professor Sexton.

In addition to peer-reviewed research, this special issue will also contain a number of Reviews and Perspectives from field leaders. “If you have an idea for a Review or Perspective that you would like to be considered, please write me and Perspectives and Reviews Editor Denise Wootten at,” saysProfessor Sexton.

You can find the entire ACS Pharmacology & Translational Science scope below. “If you are not sure if your research is within scope, please email me at, and I can provide rapid feedback on this,” says Professor Sexton.

ACS Pharmacology & Translational Science’s Scope

ACS Pharmacology & Translational Science publishes high-quality, innovative research across the broad spectrum of biological sciences —from basic and molecular sciences to translational preclinical studies. Its editors also consider clinical studies that address novel mechanisms of action and methodological papers that provide innovation and advance translation.

The journal’s editors give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest, but they will consider all innovative research with articulated translational relevance.

ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.

Learn more about why you should publish your research with ACS Pharmacology & Translational Science.

Want more stories like this delivered to your inbox?

Sign up for our newsletter to receive a selection of stories related to your favorite topics.

  • This field is for validation purposes and should be left unchanged.